Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water-treatment plant by Stackelberg, Paul E. et al.
University of Nebraska - Lincoln 
DigitalCommons@University of Nebraska - Lincoln 
USGS Staff -- Published Research US Geological Survey 
2004 
Persistence of pharmaceutical compounds and other organic 
wastewater contaminants in a conventional drinking-water-
treatment plant 
Paul E. Stackelberg 
U.S. Geological Survey, pestack@usgs.gov 
Edward T. Furlong 
U.S. Geological Survey 
Michael T. Meyer 
U.S. Geological Survey, mmeyer@usgs.gov 
Steven D. Zaugg 
U.S. Geological Survey 
Alden K. Henderson 
Centers for Disease Control and Prevention 
See next page for additional authors 
Follow this and additional works at: https://digitalcommons.unl.edu/usgsstaffpub 
 Part of the Earth Sciences Commons 
Stackelberg, Paul E.; Furlong, Edward T.; Meyer, Michael T.; Zaugg, Steven D.; Henderson, Alden K.; and 
Reissman, Dori B., "Persistence of pharmaceutical compounds and other organic wastewater 
contaminants in a conventional drinking-water-treatment plant" (2004). USGS Staff -- Published Research. 
443. 
https://digitalcommons.unl.edu/usgsstaffpub/443 
This Article is brought to you for free and open access by the US Geological Survey at DigitalCommons@University of 
Nebraska - Lincoln. It has been accepted for inclusion in USGS Staff -- Published Research by an authorized 
administrator of DigitalCommons@University of Nebraska - Lincoln. 
Authors 
Paul E. Stackelberg, Edward T. Furlong, Michael T. Meyer, Steven D. Zaugg, Alden K. Henderson, and Dori 
B. Reissman 
This article is available at DigitalCommons@University of Nebraska - Lincoln: https://digitalcommons.unl.edu/
usgsstaffpub/443 
Science of the Total Environment 329 (2004) 99–113
0048-9697/04/$ - see front matter  2004 Elsevier B.V. All rights reserved.
doi:10.1016/j.scitotenv.2004.03.015
Persistence of pharmaceutical compounds and other organic
wastewater contaminants in a conventional drinking-water-
treatment plant
Paul E. Stackelberg *, Edward T. Furlong , Michael T. Meyer , Steven D. Zaugg ,a, b c b
Alden K. Henderson , Dori B. Reissmand d
US Geological Survey, 810 Bear Tavern Road, West Trenton, NJ 08628, USAa
US Geological Survey, Box 25046, MS 407, Denver, CO 80225-0046, USAb
US Geological Survey, 4500 SW 40th Avenue, Ocala, FL 34474, USAc
Centers for Disease Control and Prevention, 1600 Clifton Road, MS E23, Atlanta, GA 30333, USAd
Accepted 18 March 2004
Abstract
In a study conducted by the US Geological Survey and the Centers for Disease Control and Prevention, 24 water
samples were collected at selected locations within a drinking-water-treatment (DWT) facility and from the two
streams that serve the facility to evaluate the potential for wastewater-related organic contaminants to survive a
conventional treatment process and persist in potable-water supplies. Stream-water samples as well as samples of raw,
settled, filtered, and finished water were collected during low-flow conditions, when the discharge of effluent from
upstream municipal sewage-treatment plants accounted for 37–67% of flow in stream 1 and 10–20% of flow in
stream 2. Each sample was analyzed for 106 organic wastewater-related contaminants (OWCs) that represent a
diverse group of extensively used chemicals. Forty OWCs were detected in one or more samples of stream water or
raw-water supplies in the treatment plant; 34 were detected in more than 10% of these samples. Several of these
compounds also were frequently detected in samples of finished water; these compounds include selected prescription
and non-prescription drugs and their metabolites, fragrance compounds, flame retardants and plasticizers, cosmetic
compounds, and a solvent. The detection of these compounds suggests that they resist removal through conventional
water-treatment processes. Other compounds that also were frequently detected in samples of stream water and raw-
water supplies were not detected in samples of finished water; these include selected prescription and non-prescription
drugs and their metabolites, disinfectants, detergent metabolites, and plant and animal steroids. The non-detection of
these compounds indicates that their concentrations are reduced to levels less than analytical detection limits or that
they are transformed to degradates through conventional DWT processes. Concentrations of OWCs detected in
finished water generally were low and did not exceed Federal drinking-water standards or lifetime health advisories,
although such standards or advisories have not been established for most of these compounds. Also, at least 11 and
as many as 17 OWCs were detected in samples of finished water. Drinking-water criteria currently are based on the
toxicity of individual compounds and not combinations of compounds. Little is known about potential human-health
effects associated with chronic exposure to trace levels of multiple OWCs through routes such as drinking water. The
occurrence in drinking-water supplies of many of the OWCs analyzed for during this study is unregulated and most
*Corresponding author. Tel.: q1-609-771-3951; fax: q1-609-771-3915.
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of these compounds have not been routinely monitored for in the Nation’s source- or potable-water supplies. This
study provides the first documentation that many of these compounds can survive conventional water-treatment
processes and occur in potable-water supplies. It thereby provides information that can be used in setting research
and regulatory priorities and in designing future monitoring programs. The results of this study also indicate that
improvements in water-treatment processes may benefit from consideration of the response of OWCs and other trace
organic contaminants to specific physical and chemical treatments.
 2004 Elsevier B.V. All rights reserved.
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1. Introduction
During the 1990s, pharmaceutically active com-
pounds such as lipid-regulating drugs, analgesics,
antibiotics, antiseptics, hormones, and chemother-
apy and beta-blocking heart drugs were detected
in wastewaters, streams, and ground-water
resources across Europe (Heberer and Stan, 1997;
Buser et al., 1998a,b, 1999). Although pharmaceu-
tically active compounds had been detected pre-
viously in effluent from landfills (Turner et al.,
1993; Holm et al., 1995) and sewage-treatment
plants (STPs) (Hignite and Azarnoff, 1977), these
more recent investigations indicated that some
pharmaceutically active compounds are nearly
ubiquitous at low concentrations in water bodies
that receive STP effluent. Reviews of the occur-
rence, fate, and effects of pharmaceutically active
compounds in the environment are available (Rich-
ardson et al., 1985; Halling-Sorensen et al., 1998;
Daughton, 2001; Ternes, 2001).
During 1999–2000, Kolpin et al. (2002) con-
ducted a reconnaissance of pharmaceuticals and
other wastewater-related contaminants in suscepti-
ble streams across the United States, expanding
the scope of previous investigations and providing
the first nationwide data set of this type. Results
of this reconnaissance survey document that a
wide variety of organic compounds are frequently
detected in streams that receive agricultural,
domestic, and (or) industrial wastewater effluent.
These contaminants include antibiotics, other pre-
scription drugs, non-prescription drugs, animal and
plant steroids, reproductive hormones, personal-
care products, detergent metabolites, flame retar-
dants, products of oil use and combustion, and
other extensively used chemicals, collectively
referred to as organic wastewater contaminants
(OWCs).
Measures to conserve and reuse water common-
ly are initiated in areas with growing urban popu-
lations and constraints on the development of new
water sources. These measures include the use of
treated municipal wastewater to augment raw-
water supplies—a process referred to as indirect
potable water reuse (IPWR) (National Research
Council, 1998). The presence of OWCs in waste-
water effluent is one of the most challenging
aspects of IPWR because of the large number of
compounds that may be present, the inability to
determine all of these compounds, and the lack of
toxicity information and drinking-water standards
for many of them (National Research Council,
1998). The frequent occurrence of these com-
pounds in streams (Kolpin et al., 2002), some of
which are used as sources of drinking water, gives
rise to concern over the potential for these com-
pounds to occur in drinking water and, thus, to
affect human health through chronic exposure.
To date, few studies have been published con-
cerning the occurrence of OWCs in drinking-water
supplies (Kummerer, 2001). Notable exceptions¨
include the detection of the pharmaceuticals phen-
azone and propiphenazone and the drug metabo-
lites clofibric acid and 1-acetyl-1-methyl-
2-dimethyl-oxamoyl-2-phenylhydrazide in samples
of potable water collected in the vicinity of Berlin,
Germany (Heberer and Stan, 1997; Reddersen et
al., 2002), and the detection of three widely used
non-prescription drugs—caffeine, cotinine, and
acetaminophen—in samples of potable water col-
lected near Atlanta, Georgia (Frick et al., 2001).
The objective of this study, conducted by the
US Geological Survey (USGS) and the Centers
for Disease Control and Prevention, was to build
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on the above-mentioned investigations by exam-
ining a wider variety of OWCs in order to further
assess the potential for these compounds to survive
conventional water treatment and occur in fin-
ished-water supplies. The occurrence of many of
these compounds in drinking water is unregulated
and most of them have not been routinely moni-
tored for in the Nation’s source- and potable-water
supplies. By documenting the occurrence of a
broad suite of OWCs in source- and potable-water
supplies, results of this study can be used in setting
monitoring, research, and regulatory priorities, and
in designing appropriate chemical and toxicologi-
cal studies and risk assessments to address more
fully the potential health effects associated with
IPWR.
This paper documents the occurrence of select
OWCs in 24 samples of stream, raw, settled,
filtered, and finished water associated with a drink-
ing-water-treatment (DWT) facility. Although
these OWCs represent a diverse group of chemi-
cals with a wide variety of uses, they account for
only a fraction of the thousands of organic com-
pounds that currently are manufactured and used
for therapeutic purposes or that occur in various
consumer and household, industrial and commer-
cial, or agricultural products. This study, therefore,
does not provide information on all of the OWCs
that may occur in source- or potable-water sup-
plies; rather, it documents the occurrence of select-
ed organic contaminants representing a wide
variety of uses and origins in environmental waters
and in potable-water supplies.
2. Description of site and sampling methods
The DWT facility from which samples were
collected during this study is in a heavily populat-
ed, highly urbanized drainage basin. More than 50
STPs discharge effluent to the two streams from
which the DWT facility withdraws its raw-water
supplies or to tributaries of these streams. Samples
of stream water were collected from the streams
that provide raw water to the DWT facility (Fig.
1a). USGS personnel collected all stream samples
using standard depth- and width-integrating tech-
niques (Shelton, 1994) and water-quality sampling
field protocols (US Geological Survey, 1998). At
each site, a composite sample of unfiltered water
was collected from approximately 10 vertical pro-
files and then split into baked, 1-liter (l) amber
glass bottles that were immediately chilled and
shipped to participating laboratories. The sampling
site on stream 2 was located approximately 30
meters (m) upstream from a source-water intake
(Fig. 1a). Stream 2 flows into stream 1 approxi-
mately 6175 m upstream from a source-water
intake on stream 1. In order to distinguish the
chemical signature of each stream, the sampling
site for stream 1 was located just upstream from
their confluence (Fig. 1a). This design allows for
the identification of differences in chemical occur-
rence associated with each stream but does not
account for sources that may be present between
their confluence and the source-water intake on
stream 1. A STP located along this reach of stream
1 discharges an average of 7 million gallons per
day (Mgalyd) (Fig. 1a).
The DWT facility treats an average of 62 Mgaly
d, providing potable water to an estimated 850 000
people. The facility utilizes a conventional treat-
ment process that consists of the following
sequence of physical and chemical treatments: (1)
raw-water screening – the movement of raw water
past a stationary bar rack and two traveling screens
to remove coarse debris; (2) the addition of pow-
dered activated carbon to remove taste- and odor-
causing compounds as well as organic chemicals;
(3) the addition of sulfuric acid or caustic for pH
control; (4) coagulation – the addition of coagu-
lant salts and polymers to destabilize colloidal
particles and facilitate their flocculation with other
suspended particles; (5) primary disinfection – the
addition of Na hypochlorite to inactivate pathogen-
ic microorganisms; (6) flocculation – the agitation
of coagulated water to promote the aggregation of
suspended materials; (7) sedimentation – the still-
ing of flocculated water to promote the settling of
suspended solids and floccules; (8) filtration – the
movement of water through tanks that contain
sand and either bituminous granular activated car-
bon (GAC), lignite GAC, or anthracite to retain
remaining fine solids and bacteria; (9) secondary
disinfection – the addition of Na hypochlorite to
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Fig. 1. Schematic diagram showing (a) location of stream sampling sites, surface-water intakes, and drinking-water-treatment plant,
and (b) physical and chemical processes used in drinking-water-treatment plant.
maintain a chlorine residual in the distribution
system; and (10) the addition of caustic soda to
maintain a pH of 7.8 to 8.2 for corrosion control
(Fig. 1b).
Samples of unfiltered water were collected at
selected locations in the DWT facility; raw water,
settled water, filtered water, and finished water
were collected (Fig. 1b). Plant personnel collected
the DWT-facility samples by filling baked, 1-l
amber glass bottles from spigots. These samples
were chilled immediately and sent to participating
laboratories.
All samples were collected over 4 consecutive
weeks during November and December 2001.
Stream samples were collected later than samples
of raw water in the DWT facility and the collection
of samples in the DWT facility did not completely
account for expected retention times associated
with each treatment process. To the extent that the
occurrence of some OWCs in raw-water supplies
may be transient in nature, the timing of sample
collection may introduce some degree of uncer-
tainty into the results of this study. Nonetheless,
the design of this study allows for an initial
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assessment of the occurrence and concentration of
OWCs in water at various points before, during,
and after treatment.
3. Analytical methods and quality assurance
One hundred six compounds were analyzed for
in each sample using three analytical methods
recently developed by the USGS (Table 1). Four
compounds (sulfamethoxazole, trimethoprim, caf-
feine, and cotinine) were measured by more than
one method. Descriptions of the analytical methods
and method performance characteristics are provid-
ed elsewhere (Barber et al., 2000; Kolpin et al.,
2002; Cahill et al., 2004). The list of analytes and
their reporting levels reported herein differ slightly
from those in Kolpin et al. (2002) as a result of
additions to the list of analytes and increases in
method reporting levels for the wastewater-related
compounds by continuous liquid–liquid extraction
and gas chromatographyymass spectrometry
(CLLE GCyMS). Twenty-five antibiotic com-
pounds were extracted and analyzed by tandem
solid-phase extraction (SPE) and single quadra-
pole, liquid chromatographyymass spectrometry
with electro-spray ionization set in positive mode
and selected-ion monitoring (SIM). Reporting lev-
els for the antibiotic method range from 0.02 to
2.0 mgyl (Table 1). Twenty-two human prescrip-
tion and non-prescription drugs and selected
metabolites were extracted by SPE and measured
by high performance liquid chromatographyyelec-
trospray-ionization mass spectrometry (HPLCy
ESI-MS) using a reverse-phase octylsilane (C8)
HPLC column (Cahill et al., 2004). Reporting
levels for the prescription and non-prescription
drugs method range from 0.001 to 0.24 mgyl
(Table 1). Sixty-three other OWCs were extracted
from whole-water using CLLE GCyMS (Barber et
al., 2000). Reporting levels for the wastewater-
related compounds method range from 0.5 to 5.0
mgyl (Table 1). For each method, concentrations
of constituents with confirmed detections below
the reporting level are provided. The uncertainty
associated with concentrations reported below the
reporting limit is greater than concentrations
reported above the reporting limit; therefore, con-
centrations below the reporting limit are reported
as estimates. Method recovery and precision data
are reported in Barber et al. (2000) and Cahill et
al. (2004).
One field and 27 laboratory blanks were ana-
lyzed for target compounds during the course of
this study. Blank samples were derived from lab-
oratory-grade organic-free water and were used to
determine whether sampling procedures, sampling
equipment, field conditions, or sample shipment
procedures introduced the target analytes to envi-
ronmental samples (field blank) or to assess the
potential for sample contamination in the labora-
tory (laboratory blanks). Carbamazepine, sulfa-
methoxazole, and trimethoprim were each detected
in the field blank at 0.0001 mgyl for trimethoprim,
0.0003 mgyl for carbamazepine, and 0.0009 mgyl
for sulfamethoxazole. These concentrations are
well below the reporting levels for these com-
pounds (Table 1) and reflect (1) the sensitivity for
detecting these compounds by HPLCyESI-MS;
and (2) possible low-level carryover between
instrumental analysis. Carbamazepine was detected
in the associated environmental sample, but at a
concentration more than 100 times that measured
in the field blank. Sulfamethoxazole and trimeth-
oprim were not detected in the associated environ-
mental sample. Moreover, sulfamethoxazole was
detected in only one of the 24 samples collected.
Although carbamazepine and trimethoprim were
detected more frequently, concentrations of these
compounds in stream samples and samples from
the DWT facility were at least 20 times greater
than concentrations observed in the field blank.
Indole and diphenhydramine were each detected
in one laboratory blank. Indole was not detected
in any of the associated environmental samples,
whereas diphenhydramine was detected in one
associated environmental sample, but at a concen-
tration 10 times that measured in the laboratory
blank. Erythromycin-H O was detected at concen-2
trations less than 0.01 mgyl in laboratory blanks.
Erythromycin is a low-level contaminant in the
C-erythromycin surrogate standard and is con-13
verted to erythromycin-H O when the sample is2
acidified. Environmental concentrations of eryth-
romycin-H O reported herein are more than three2
times the observed background concentration in



















Wastewater-related compounds analyzed for in all samples and highest concentration detected in samples of finished water
Chemical CAS General use Reporting Detection Drinking Cancer Highest
number level frequency water group concentration
(mgyl) in stream standards in sample of
and raw- and health finished
water samples advisories water
(ns12) (mgyl) (mgyl)
Antibiotics by LCMS
Carbadox 6804-07-5 Antibiotic 0.10 0 – – ND
Chlortetracycline 57-62-5 Antibiotic 0.05 0 – – ND
Ciprofloxacin 85721-33-1 Antibiotic 0.02 0 – – ND
Demeclocycline 127-33-3 Antibiotic 0.05 0 – – ND
Doxycycline 564-25-0 Antibiotic 0.1 0 – – ND
Enrofloxacin 93106-60-6 Antibiotic 0.02 0 – – ND
Erythromycin-H O2 – Erythromycin 0.05 67 – – ND
metabolite
Lincomycin 154-21-2 Antibiotic 0.05 0 – – ND
Methotrexate 59-05-2 Antibiotic 0.05 0 – – ND
Minocycline 10118-90-8 Antibiotic 0.05 0 – – ND
Norfloxacin 70458-96-7 Antibiotic 0.02 0 – – ND
Oxytetracycline 79-57-2 Antibiotic 0.1 0 – – ND
Roxarsone 121-19-7 Antibiotic 2.0 0 – – ND
Roxithromycin 80214-83-1 Antibiotic 0.03 0 – – ND
Sarafloxacin 98105-99-8 Antibiotic 0.02 0 – – ND
Sulfadimethoxine 122-11-2 Antibiotic 0.05 0 – – ND
Sulfamerazine 127-79-7 Antibiotic 0.05 0 – – ND
Sulfamethazine 57-68-1 Antibiotic 0.05 0 – – ND
Sulfamethizole 144-82-1 Antibiotic 0.05 0 – – ND
Sulfamethoxazole1 723-46-6 Antibiotic 0.05 8 – – ND
Sulfathiazole 72-14-0 Antibiotic 0.10 0 – – ND
Tetracycline 60-54-8 Antibiotic 0.05 0 – – ND
Trimethoprim1 738-70-5 Antibiotic 0.03 0 – – ND
Tylosin 1401-69-0 Antibiotic 0.05 0 – – ND
Virginiamycin 21411-53-0 Antibiotic 0.10 0 – – ND
Prescription and non-prescription drugs by
HPLCyESI-MS
1,7-dimethylxanthine 611-59-6 Caffeine metabolite 0.018 75 – – ND
Acetaminophen 103-90-2 Antipyretic 0.009 50 – – ND
Albuterol 18559-94-9 Antiasthmatic 0.029 8 – – ND
Caffeine2 58-08-2 Stimulant 0.014 100 – – 0.119
Carbamazepine 298-46-4 Anticonvulsant 0.011 100 – – 0.258



















Chemical CAS General use Reporting Detection Drinking Cancer Highest
number level frequency water group concentration
(mgyl) in stream standards in sample of
and raw- and health finished
water samples advisories water
(ns12) (mgyl) (mgyl)
Codeine 76-57-3 Analgesic 0.24 25 – – ND
Cotinine2 486-56-6 Nicotine metabolite 0.023 100 – – 0.025
Dehydronifedipine 67035-22-7 Nifedipine metabolite 0.01 50 – – 0.004
Digoxigenin 1672-46-4 Digoxin metabolite 0.008 0 – – ND
Diltiazem 42399-41-7 Antihypertensive 0.012 0 – – ND
Diphenhydramine 58-73-1 Antihistamine 0.0148 25 – – ND
Fluoxetine 54910-89-3 Antidepressant 0.018 0 – – ND
Furosemide 54-31-9 Diuretic 0.0386 0 – – ND
Gemfibrozil 25812-30-0 Antihyperlipidemic 0.015 0 – – ND
Ibuprofen 15687-27-1 Antiinflammatory 0.018 0 – – ND
Miconazole 22916-47-8 Antifungal 0.0175 0 – – ND
Ranitidine 66357-35-5 Antacid 0.01 0 – – ND
Sulfamethoxazole1 723-46-6 Antibiotic 0.023 8 – – ND
Thiabendazole 148-79-8 Fungicide 0.0108 8 – – ND
Trimethoprim1 738-70-5 Antibiotic 0.014 83 – – ND
Warfarin 81-81-2 Anticoagulant 0.001 0 – – ND
Other wastewater-related compounds by
CLLE GCyMS
1,4-dichlorobenzene 106-46-7 Deodorizer 0.5 0 75 ; 75 ; 0.1 ; 40003 4 5 6 C ND
1-methylnapthalene 90-12-0 Fuels 0.5 0 – – ND
2,6-dimethylnapthalene 581-42-0 Fuels 0.5 0 – – ND
2-methylnapthalene 91-57-6 Fuels 0.5 0 – – ND
3-b-coprostanol 360-68-9 Fecal steroid 2 33 – – ND
3-methyl-1H-indole (skatol) 83-34-1 Fragrance 1 0 – – ND
3-tert-butyl-4-hydroxyanisole (BHA) 25013-16-5 Antioxidant 5 0 – – ND
4-cumylphenol 599-64-4 Detergent metabolite 1 0 – – ND
4-n-octylphenol 1806-26-4 Detergent metabolite 1 0 – – ND
4-nonylphenol diethoxylate (NPEO2-total) 26027-38-3 Detergent metabolite 5 58 – – ND
4-octylphenol diethoxylate (OPEO2) 26636-32-8 Detergent metabolite 1 0 – – ND
4-octylphenol monoethoxylate (OPEO1) 26636-32-8 Detergent metabolite 1 0 – – ND
4-tert-octylphenol 140-66-9 Detergent metabolite 1 8 – – ND
5-methyl-1H-benzotriazole 136-85-6 Anticorrosive 2 0 – – ND
Acetophenone 98-86-2 fragrance 0.5 0 – – ND
7-acetyl-1,1,3,4,4,6-hexamethyl tetrahydronaphthalene 21145-77-7 Fragrance 0.5 100 – – 0.49
(AHTN)
Anthracene 120-12-7 PAH 0.5 0 0.3 ; 10 0005 6 D ND



















Chemical CAS General use Reporting Detection Drinking Cancer Highest
number level frequency water group concentration
(mgyl) in stream standards in sample of
and raw- and health finished
water samples advisories water
(ns12) (mgyl) (mgyl)
Benzowaxpyrene 50-32-8 PAH 0.5 42 0.23 B2 ND
Benzophenone 119-61-9 Fixative 0.5 58 – – 0.13
b-sitosterol 83-46-5 Plant steroid 2 83 – – ND
b-stigmastanol 19466-47-8 Plant steroid 2 8 – – ND
Bisphenol A 80-05-7 Plasticizer 1 100 – – 0.42
Bromacil 314-40-9 Herbicide 0.5 0 90 ; 0.1 ; 50004 5 6 C ND
Bromoform7 75-25-2 Trihalomethane 0.5 50 80 ; 0.02 ; 7003 5 6 B2 21
Caffeine2 58-08-2 Stimulant 0.5 100 – – ND
Camphor 76-22-2 Flavorant 0.5 0 – – ND
Carbaryl 63-25-2 Insecticide 1 0 700 ; 0.1 ; 40004 5 6 D ND
Carbazole 86-74-8 Insecticide 0.5 17 – – ND
Chlorpyrifos 2921-88-2 Insecticide 0.5 0 20 ; 0.003 ; 1004 5 6 D ND
Cholesterol 57-88-5 Plantyanimal steroid 2 83 – – ND
Cotinine2 486-56-6 Nicotine metabolite 1 0 – – ND
Diazinon 333-41-5 Insecticide 0.5 0 – – ND
d-dichlorvos 62-73-7 Insecticide 1 0 – – ND
d-limonene 5989-27-5 Fungicide 0.5 0 – – ND
Fluoranthene 206-44-0 PAH 0.5 8 – – ND
1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethyl 1222-05-5 Fragrance 0.5 92 – – 0.082
Cyclopenta-g-2-benzopyran (HHCB)
Indole 120-72-9 Pesticide inert 0.5 0 – – ND
Isoborneol 124-76-5 Fragrance 0.5 0 – – ND
Isophorone 78-59-1 Solvent 0.5 0 100 ; 0.2 ; 70004 5 6 C ND
Isopropylbenzene (cumene) 98-82-8 Fuels 0.5 0 0.1 ; 40005 6 D ND
Isoquinoline 119-65-3 Flavorant 0.5 0 – – ND
Menthol 89-78-1 Fragrance 0.5 0 – – ND
Metalaxyl 57837-19-1 Fungicide 0.5 0 – – ND
Methyl salicylate 119-36-8 Liniment 0.5 0 – – ND
Metolachlor 51218-45-2 Herbicide 0.5 0 100 ; 0.15 ; 5004 5 6 C ND
N,N-diethyl-meta-toluamide (DEET) 134-62-3 Insecticide 0.5 25 – – 0.066
Naphthalene 91-20-3 PAH 0.5 0 100 ; 0.02 ; 7004 5 6 C ND
Para-cresol 106-44-5 Wood preservative 1 0 – – ND
Para-nonylphenol (total, NP) 84852-15-3 Detergent metabolite 5 0 – – ND
Pentachlorophenol 87-86-5 Wood preservative 2 33 1 ; 0.03 ; 10003 5 6 B2 ND
Phenanthrene 85-01-8 PAH 0.5 0 D ND
Phenol 108-95-2 Disinfectant 0.5 67 4000 ; 0.6 ; 20 0004 5 6 D ND



















Chemical CAS General use Reporting Detection Drinking Cancer Highest
number level frequency water group concentration
(mgyl) in stream standards in sample of
and raw- and health finished
water samples advisories water
(ns12) (mgyl) (mgyl)
Pyrene 129-00-0 PAH 0.5 8 0.035 D ND
Tetrachloroethylene 127-18-4 Solvent 0.5 58 5 ; 10 ; 0.01 ; 5003 4 5 6 – 0.1
Tri(2-butoxyethyl) phosphate 78-51-3 Plasticizer 0.5 83 – – 0.35
Tri(2-chloroethyl) phosphate 115-96-8 Flame retardant 0.5 100 – – 0.099
Tri(dichlorisopropyl) phosphate 13674-87-8 Flame retardant 0.5 100 – – 0.25
Tributyl phosphate 126-73-8 Flame retardant 0.5 83 – – 0.1
Triclosan 3380-34-5 Antimicrobial disinfectant 1 67 – – ND
Triethyl citrate (ethyl citrate) 77-93-0 Cosmetics 0.5 50 – – 0.062
Triphenyl phosphate 115-86-6 Plasticizer 0.5 0 – – ND
CAS number: chemical abstract service number; B2: probable human carcinogen (US Environmental Protection Agency, 2002); C: possible human carcinogen (US
Environmental Protection Agency, 2002); D: not classifiable as to human carcinogenicity (US Environmental Protection Agency, 2002); LCMS: liquid chromatographyy
electrospray ionization mass spectrometry; HPLCyESI-MS: high performance liquid chromatographyymass spectrometry; CLLE GCyMS: continuous liquid – liquid
extraction with gas chromatographyymass spectrometry; PAH; polycyclic aromatic hydrocarbon; ND: not detected; –: no data; compounds suspected of being hormonally
active are in bold.
Compound analyzed by LCMS and HPLCyESI-MS.1
Compound analyzed by HPLCyESI-MS and CLLE GCyMS.2
US Environmental Protection Agency maximum contaminant level (mgyl) (US Environmental Protection Agency, 2002).3
US Environmental Protection Agency lifetime health advisory (mgyl) (US Environmental Protection Agency, 2002).4
US Environmental Protection Agency reference dose (mgykgyday) (US Environmental Protection Agency, 2002).5
US Environmental Protection Agency drinking water equivalent level (mgyl) (US Environmental Protection Agency, 2002).6
1998 final rule for disinfection by-products: the total for trihalomethanes is 80 mgyl (US Environmental Protection Agency, 2002).7
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were not detected in any of the laboratory blanks.
These results indicate that sample-collection pro-
cedures, sampling equipment, field conditions, and
laboratory procedures did not systematically intro-
duce any of the target compounds into field sam-
ples at concentrations relevant to observed environ-
mental concentrations.
4. Results
Stream samples were collected during low-flow
conditions. Long-term mean daily flows at three
nearby gaging stations on the two source streams
were compared to flow rates at the gaging stations
at the time of stream-sample collection. On the
basis of 22–115 years of record, flow rates at the
gaging stations ranged from as little as approxi-
mately 3% to no more than approximately 30% of
long-term mean daily values. On the basis of
average seasonal volumes of STP effluent in each
stream and flow rates at the time of sample
collection, 37–67% of the flow in stream 1 and
10–20% of the flow in stream 2 consisted of STP
effluent (Fig. 1a). Furthermore, during such low-
flow conditions, some of the flow in stream 1 is
diverted into stream 2 to accommodate the volume
of water withdrawn at surface-water intake 2 (Fig.
1a). Results reported here pertain only to these
conditions and should not be assumed to be rep-
resentative of water-quality conditions during high-
er flow conditions.
Forty compounds were detected in samples of
stream water or raw-water supplies in the DWT
plant; 34 were detected in more than 10% of these
samples (Fig. 2). Seven compounds were detected
in each sample of stream water and raw-water
supplies: 7-acetyl-1,1,3,4,4,6-hexamethyl tetrahy-
dronaphthalene (AHTN) (a fragrance compound),
bisphenol A (a compound used as a manufacturing
intermediate, as a component in flame retardants
and rubber chemicals, and as a fungicide), caffeine
(a stimulant found in coffee, tea, and other bev-
erages), carbamazepine (an anticonvulsant and
specific analgesic for trigeminal neuralgia), cotin-
ine (a metabolite of nicotine), tri(2-chloroethyl)
phosphate (a flame retardant and plasticizer), and
tri(dichloroisopropyl) phosphate (a flame retar-
dant) (Fig. 2). Compounds detected in 75% or
more of these samples are 1,3,4,6,7,8-hexahydro-
4,6,6,7,8,8-hexamethyl cyclopenta-g-2-benzopyran
(HHCB) (a fragrance compound), b-sitosterol and
cholesterol (plant and animal steroids), tri(2-
butoxyethyl) phosphate (a plasticizer and flame
retardant), tributyl phosphate (a plasticizer), tri-
methoprim (an antibiotic), and 1,7-dimethylxan-
thine (a metabolite of caffeine) (Fig. 2). Many of
these compounds likely are derived from domestic
and (or) industrial wastewaters that are processed
through municipal STPs. These facilities, however,
generally are designed to remove suspended solids
and oxygen-demanding substances and, for ad-
vanced sewage treatment, to remove dissolved
inorganic constituents such as phosphate. STPs are
not specifically designed to remove organic con-
taminants that are likely to be present in domestic
and industrial wastewaters at trace levels. Low
concentrations of these OWCs, therefore, are likely
to be present in effluent from municipal STPs; the
incomplete removal of pharmaceuticals from was-
tewater has previously been documented (Stumpf
et al., 1999; Heberer, 2002). Although most of the
more frequently detected organic compounds likely
are derived from domestic and (or) industrial
wastewaters, some compounds could be derived
from non-point sources or sources unrelated to
human activities.
Several compounds that were frequently detect-
ed in samples of stream water and raw-water
supplies also were frequently detected in samples
collected throughout the DWT plant, indicating
that these compounds resist removal through con-
ventional water-treatment processes (Fig. 3). The
concentrations of several compounds (e.g. HHCB,
tetrachloroethylene, tri(2-chloroethyl) phosphate,
and tributyl phosphate) are consistent across sam-
pling events and throughout the treatment process,
suggesting temporally constant concentrations in
the source streams and little or no removal through
conventional water treatment (Fig. 3). The consis-
tent concentrations of these compounds across
sampling events corroborate analytical method per-
formance as described elsewhere (Barber et al.,
2000; Kolpin et al., 2002; Cahill et al., 2004). The
concentrations of other compounds (e.g. AHTN,
bisphenol A, caffeine, and carbamazepine) are
more variable across sampling events and through-
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Fig. 2. Concentrations and frequency of detection of compounds detected in more than 10% of samples of stream water and raw-
water supplies in the drinking-water-treatment plant.
out the treatment process, indicating that the con-
centrations of these compounds in the source
streams are temporally more variable and, possibly,
that the concentrations of these compounds may
be reduced through the DWT process (Fig. 3).
The concentrations of these compounds in finished
water (Fig. 4) generally were similar to or less
than concentrations in the associated raw-water
sample, indicating that the variability in concentra-
tions of compounds such as AHTN, bisphenol A,
caffeine, and carbamazepine throughout the treat-
ment process shown in Fig. 3 is at least partly due
to a reduction in concentration along the treatment
process.
Other compounds frequently detected in samples
of stream water and raw-water supplies (e.g. cho-
lesterol, b-sitosterol, trimethoprim, 1,7-dimethy-
lxanthine, erythromycin-H O, triclosan, phenol,2
4-nonylphenol diethoxylate, and acetaminophen)
were not detected in samples of finished water,
indicating that concentrations of these compounds
are effectively reduced to levels less than analytical
detection limits or that the compounds are trans-
formed through conventional water-treatment pro-
cesses to degradates not determined by the
methods used in this study.
Previous investigators have reported that filtra-
tion with GAC is effective in removing carbama-
zepine from potable-water supplies (Ternes et al.,
2002), whereas results of this study indicate that
carbamazepine and other hydrophobic compounds
such as AHTN and HHCB persist through DWT
that includes filtration with GAC. Sorption effi-
ciencies depend on competition with other organic
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Fig. 4. Concentrations of selected compounds in samples of
raw and finished water.
Fig. 3. Concentrations of selected compounds in samples of raw (circles), settled (triangles), filtered (squares), and finished (inverted
triangles) water.
compounds; therefore, the adsorption capacity for
carbamazepine and other OWCs in a DWT facility
that processes raw water that contains substantial
amounts of many naturally occurring and anthro-
pogenic organic compounds is expected to be
smaller than that in laboratory and pilot-scale
experiments in which fresh activated carbon and
deionized water were used (Ternes et al., 2002).
At the time of this study, the GAC filters in the
DWT plant were approximately 3 years old and
were used primarily to control odor- and taste-
causing compounds in chlorinated water, with
contact times ranging from approximately 1.5 to 3
min. Because previous investigators did not detect
carbamazepine in potable-water supplies (Ternes
et al., 2002), the presence of this compound in
raw, filtered, settled, and finished water samples
was verified using two additional mass spectro-
metric methods: high-performance liquid chroma-
tographyytandem mass spectrometry with an
ion-trap mass spectrometer (HPLCyIT-MSyMS;
Bruker Daltonics Esquire) and high-performance
liquid chromatographyytime-of-flight mass spec-
trometry (HPLCyTOF-MS; Micromass LCT). In
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all samples, HPLCyIT-MSyMS analysis of the
putative carbamazepine peak in samples produced
a protonated molecular ion at the retention of a
carbamazepine standard. MSyMS analysis of this
carbamazepine ion (myz 237) in all samples result-
ed in fragmentation yielding an ion of myz 194,
reflecting a loss of CONH, consistent with a loss
and rearrangement of the carbamazepine proton-
ated molecular ion. In all samples, the elemental
composition of the suspected carbamazepine peak
by HPLCyTOF-MS was consistent with the ele-
mental composition of carbamazepine within 1.5
millidaltons. For the protonated molecular ion of
carbamazepine, that converts to a mass accuracy
error of no greater than 6 parts per million, well
within the criteria commonly accepted for accurate
mass determination. AHTN and HHCB detections
in all samples were verified by full scan mass
spectrometry analysis using careful comparison of
each samples spectrum to a custom library spec-
trum made from authentic standards run on the
same analytical instrument.
5. Discussion
Results of this study demonstrate that OWCs
such as prescription and non-prescription drugs
and their metabolites, fragrances, flame retardants,
plasticizers, disinfectants, personal care products,
detergent metabolites, products of oil use and
combustion, and other extensively used chemicals
are frequently detected in streams whose flow
contains effluent from municipal STPs. These
results corroborate those of Kolpin et al. (2002).
Furthermore, this study demonstrates that some of
these contaminants survive conventional DWT
processes and occur in potable-water supplies,
whereas others are reduced to non-detectable con-
centrations through conventional DWT processes.
The occurrence of many of these contaminants in
drinking water is unregulated and this study pro-
vides the first documentation of their occurrence
in drinking-water supplies. This information can
be used in setting research and regulatory priorities
and in designing future monitoring programs.
Concentrations of the OWCs that were detected
in finished water during this study generally were
low (93% -0.5 mgyl) (Fig. 2), and in the cases
where standards have been established, did not
exceed Federal drinking-water standards or life-
time health advisories. Most of these compounds,
however, do not currently have established drink-
ing-water standards or health advisories (Table 1);
therefore, the potential health consequences asso-
ciated with exposure through drinking water are
not known. Concentrations in finished water of
OWCs designed for human consumption, such as
prescription and non-prescription drugs, were far
below doses used in therapy. For example, the
maximum possible intake of carbamazepine in
finished water in a lifetime (assuming an intake
of 2 l per day for 70 years) was 13 mg, whereas
a single therapeutic dose generally is 100 mg or
greater. Nevertheless, most studies on the thera-
peutic effects of drugs are based on the short-term
ingestion of relatively high doses; little is known
about potential health effects associated with long-
term chronic ingestion of low concentrations
through drinking water (Kummerer, 2001). More-¨
over, drinking-water criteria currently are based on
the toxicity of individual compounds and not
combinations of compounds. The possibility that
exposure to multiple organic compounds, even at
low concentrations, may have a synergistic human-
health consequence is an area of recent research
(Birader and Rayburn, 1995; Marinovich et al.,
1996), and the co-occurrence of organic com-
pounds in drinking-water supplies has recently
been documented (Stackelberg et al., 2001; Squil-
lace et al., 2002). In this study, 11–17 different
OWCs were detected in each of the four samples
of finished water.
Whereas some frequently detected OWCs, such
as pharmaceutical compounds, are designed to be
ingested, others (e.g. flame retardants, solvents,
and other personal care and industrial chemicals)
are not designed for human consumption. The
human-health consequence of chronic ingestion of
these compounds is even less well understood than
that of categories of OWCs such as pharmaceutical
compounds. Some of these compounds (e.g. bis-
phenol A) are known or suspected endocrine
disruptors and may be potent reproductive toxins
even at low concentrations.
Although only a small number of degradate
compounds were analyzed for in this study, several
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of the most frequently detected OWCs are degra-
dates (e.g. cotinine, dehydronifedipine, erythro-
mycin-H O, and 1,7-dimethylxanthine, degradates2
of nicotine, nifedipine, erythromycin, and caffeine,
respectively); thus, the formation of degradates
may represent a substantial component of the total
transport of OWCs through DWT processes. This
finding demonstrates the importance of analyzing
for degradates in order to understand fully the fate
of OWCs in a DWT facility as well as the potential
human-health issues associated with chronic expo-
sure to these compounds through drinking water.
For other classes of organic compounds, such as
pesticides, the importance of analyzing for degra-
dates is well established (Thurman et al., 1994;
Kolpin et al., 1997; Kalkhoff et al., 1998; Graham
et al., 1999; Kolpin et al., 2001). The absence of
many OWCs in finished-water supplies, therefore,
does not necessarily imply their complete removal
from finished water. Rather, the treatment process
may transform parent OWCs to unknown and (or)
unmeasured degradates. Additional methods devel-
opment and sample analysis will be required to
address these issues.
The limited number of samples (ns4) collected
at each site for this study and the fact that the
collection of grab samples in the DWT plant did
not adequately account for expected retention
times throughout treatment preclude quantification
of the effectiveness of each treatment process in
reducing the concentrations of these contaminants.
Additional sampling will provide information
about (1) temporal variability of OWCs in source
waters; (2) effectiveness of specific physical and
chemical treatments in reducing the concentrations
of the target OWCs; and (3) which primary phys-
ical processes and (or) chemical reactions reduce
the concentrations of or eliminate OWCs. Only a
small subset of the thousands of organic com-
pounds that are currently in use and potentially
could occur in domestic and industrial wastewaters
were determined; however, this study indicates
that at least some organic compounds can enter
and persist in environmental waters and also may
survive subsequent water-treatment processes. The
technology to analyze for all known organic com-
pounds is currently unavailable and, therefore, the
complete extent of occurrence of OWCs in drink-
ing-water supplies is unknown. The challenge for
future studies is to develop the means to charac-
terize the types and concentrations of these com-
pounds that are likely to co-occur in drinking-water
supplies and to assess their potential effects.
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